Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Alternatives · ranked for women
Alternatives to RxSpan MD
RxSpan MD lands at #19 on our women's ranking with a Luna Fit Score of 81/100 — what we found reviewing RxSpan MD goes through the six factors behind that number. If it isn't the right fit, here are the strongest alternatives for women's GLP-1 care — scored on the same women's-health rubric of PCOS suitability, clinical oversight, price, access, support and fair cancellation.
Our #1 pick for women
Luna Fit
93/100
Ranked #1 · Grade A
CoreAge Rx
The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
Everything below is scored on the same six women's-health factors as RxSpan MD, in our overall ranking order — our complete review index has the rest of the ranking.
HealthRX
Ranked #6 · Grade B
Luna Fit
85/100
A LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injections — both molecules, transparent no-insurance pricing, and an accreditation signal that reassures when hormones are in play.
One of the few programs here that puts both molecules in an oral form as well as an injection, alongside a real brand-name Ozempic lane — and it names the physicians behind the prescription, which few rows here do.
An insurance-first GLP-1 marketplace that shops a reader's coverage for her — down to $99/mo with qualifying insurance, or $50/mo for eligible Medicare Part D members through its CMS Bridge program — with one of the widest medication menus in this ranking, including an oral pill option.
One of the few programs we track that offers an oral or sublingual route alongside injections — semaglutide drops from about $179 (or $297 injectable), tirzepatide from about $224 — all-inclusive with no separate membership. The trade-off is a newer, less-verified operator whose prices we couldn't confirm live.
One of the most complete feature sets we review for women: both molecules, an oral option, FDA-approved brand access, and LegitScript accreditation, all nationwide.
An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.
A tiered compounded program that lays every price on the table — semaglutide, tirzepatide, a microdose lane, and a combo option — with six-month metabolic lab testing and an NAD+ adjacency that speaks to women thinking about metabolism as a whole system.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.